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Abstract
Background:  The 2,2,7-trimethylguanosine (TMG) cap structure is an important functional
characteristic of ncRNAs with critical cellular roles, such as some snRNAs. Here we used
immunoprecipitation with both K121 and R1131 anti-TMG antibodies to systematically identify the
TMG cap structures for all presently characterized ncRNAs in C. elegans.
Results: The two anti-TMG antibodies precipitated a similar group of the C. elegans ncRNAs. All
snRNAs known to have a TMG cap structure were found in the precipitate, indicating that our
identification system was efficient. Other ncRNA families related to splicing, such as SL RNAs and
Sm Y RNAs, were also found in the precipitate, as were 7 C/D box snoRNAs. Further analysis
showed that the SL RNAs and the Sm Y RNAs shared a very similar Sm binding site element (AAU4–
5GGA), which sequence composition differed somewhat from those of other U snRNAs. There
were also 16 ncRNAs without an Sm binding site element in the precipitate, suggesting that for
these ncRNAs, TMG formation may occur independently of Sm proteins.
Conclusion:  Our results showed that most ncRNAs predicted to be transcribed by RNA
polymerase II had a TMG cap, while those predicted to be transcribed by RNA plymerase III or
located in introns did not have a TMG cap structure. Compared to ncRNAs without a TMG cap,
TMG-capped ncRNAs tended to have higher expression levels. Five functionally non-annotated
ncRNAs also have a TMG cap structure, which might be helpful for identifying the cellular roles of
these ncRNAs.
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Background
The 2,2,7-trimethylguanosine (TMG) cap structure was
first found at the 5'-end of low-molecular-weight nuclear
RNAs, such as U1 small nuclear RNAs (snRNA), U2
snRNA, U5 snRNA and U3 small nucleolar RNAs (snoR-
NAs) from Novikoff hepatoma cells (reviewed in [1]). In
nematodes and some other metazoans, 5'-end TMG caps
have been extensively characterized for trans-spliced
mRNAs and functional non-coding RNAs (ncRNAs), such
as U1, U2, U4 and U5 snRNAs, and for some of the snoR-
NAs and spliced leader (SL) RNAs [2]. All TMG-capped
snRNAs are transcribed by RNA polymerase II.
In mammals, hypermethylation of the m7G cap of the U1,
U2, U4, and U5 snRNAs to a TMG cap occurs in the cyto-
plasm, and depends on some of the Sm core proteins
[3,4]. Unlike the assembly of the spliceosomal snRNPs,
which take place in the cytoplasm, biogenesis of the verte-
brate snoRNPs takes place in the nucleolar compartment,
and hypermethylation of the TMG-capped snoRNAs is not
associated with Sm proteins [5-7]. In yeast, U1, U2, U4,
and U5 snRNAs also have a TMG cap structure [8] and
hypermethylation of the cap structure is dependent on the
Sm proteins [9,10], and a conserved methyltransferase,
which is essential for hypermethylation of the m7G caps
of snRNAs and snoRNAs[11]. Although the cellular func-
tion of the TMG cap is not clear, it is believed that the tri-
methylguanosine caps are necessary for the snRNAs to
fulfill their cellular functions [12]. The TMG cap is an
important component of the nuclear localization signal of
U snRNPs, and there is evidence that core U-snRNPs with-
out a TMG structure cannot be imported into the nucleus
[13,14].
Biochemical determination of a TMG cap structure has
traditionally required several experimental steps [15], and
antibodies that recognize specific structures has therefore
greatly facilitated screening for ncRNAs with TMG caps.
Capped ncRNAs have been purified from total cellular
RNA of vegetative microplasmodia by preparative immu-
noprecipitation with anti-TMG antibodies [16,17]. These
antibodies specifically react with TMG-capped RNAs such
as U1, U2 and U4 snRNAs. This can also be used to isolate
snRNPs in one step from nuclear extracts of eukaryotic
cells by affinity chromatography on a preparative scale
[18].
Several strategies have been endeavored to detect or dis-
cover novel ncRNAs, including both experimental and
computational screening [19-22]. Results from the recent
tiling microarray studies also indicate that far larger por-
tions of the eukaryote transcriptome than formerly
believed are actually transcribed in the form of non-cod-
ing transcripts [23]. Systemic examination of the 5'-end
TMG cap structures at the novel ncRNAs would be useful
contribution towards decoding the cellular functions of
these transcripts. Here we combined immunoprecipita-
tion and an ncRNA microarray [24] to identify 5'-end
TMG cap structures in most of the presently characterized
ncRNAs in C. elegans [19], and analyzed important char-
acters associated TMG-capped ncRNAs, such as function,
biogenesis and expression.
Results
ncRNAs precipitated by the anti-TMG antibodies
We first filtered and immunoprecipitated worm total RNA
with the K121 anti-TMG antibody. However, after having
been made aware that this antibody may have a reduced
specificity for TMG caps and has shown some cross-reac-
tivity with mono-methylated cap structures [25,26], we
repeated all subsequent experiments with the R1131 anti-
body [17]. RNAs in both precipitate and supernatant
obtained with both antibodies were extracted and
reversely transcribed. The cDNA from precipitate and
supernatant was labeled with Cy3 or Cy5, respectively,
and hybridized to a microarray with probes for 127
ncRNAs [24]. For each of the 127 ncRNAs, the intensities
of precipitation sample and supernatant sample were
examined. Most of the ncRNAs had a clear tendency to
occur either in the precipitation or in the supernatant
sample. With a few exceptions, the two TMG antibodies
precipitated the same ncRNAs, suggesting that both are
able to effectively distinguish TMG capped ncRNAs from
ncRNAs with other 5'-end structures (see below and Fig-
ure 1A). However, the data also indicated somewhat dif-
ferent specificities. For the snRNA U6, which have a
simple γ-methylguanosine cap, a larger partition of this
RNA was precipitated by K121 antibody (intensity ratio
0.55) than by R1131 antibody (intensity ratio 0.022; See
Additional file [1]). There was also a tendency towards
precipitate and supernatant obtained with R1131 show-
ing higher and lower intensity ratios, respectively, com-
pared to those obtained with K121 (Figure 1B).
To get an estimate of the baseline expression, the Cy3 (or
Cy5) intensity data from 8 repeats of mixed-stage worms
were examined. Overall, the probability of the intensity of
an ncRNA in a single repeat deviating 50% from the aver-
age was estimated to be 10%. We therefore used an inten-
sity ratio (precipitation/supernatant) of 1.5 as a threshold
for identifying TMG-capped RNAs, as at this threshold the
false positive rate would be only 10%, and no more than
two of the 127 ncRNAs studied would be falsely assigned
TMG capped (or not). At this threshold, the K121 anti-
body precipitated 37 ncRNAs whereas R1131 precipitated
36 of these (Figure 1A and Additional file [1]). As the
R1131 antibody is known to have higher specificity for
the TMG cap structure, the 36 ncRNAs that were precipi-
tated by this antibody were assigned as TMG-capped for
further analysis (Table 1).BMC Molecular Biology 2007, 8:86 http://www.biomedcentral.com/1471-2199/8/86
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Precipitation efficiency of K121 and R1131 anti-TMG antibodies Figure 1
Precipitation efficiency of K121 and R1131 anti-TMG antibodies . (A) The number of ncRNAs that were assigned into 
TMG-capped group (TMG) or non-TMG-capped group (Non-TMG), or not assigned to either group (Other) by the K121 and 
R1131 anti-TMG antibodies. (B) Fluorescence intensity ratio distribution for the R1131 or K121 antibodies.
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Detailed studies the 5'-end structures of C. elegans ncRNA
have apparently not been carried out, but all snRNAs
known to be TMG-capped in other organisms [1] were
assigned as TMG-capped in our analysis. Similarly, U6
snRNA, known to have a γ-methylated cap structure [1]
was assigned to the non-TMG-capped group. Transcripts
in ncRNA families known or assumed to be related to
splicing, such as the SL RNAs and the recent identified Sm
Y RNAs (snlRNAs in [19]) in C. elegans [24,27,28], were
assigned to the TMG-capped group. There were also 7 C/
D box snoRNAs in TMG-capped group, including U3
snoRNA, which has been shown to have a TMG cap in
other organisms [7]. There were also 5 functionally non-
annotated ncRNAs in the TMG-capped group. None of H/
ACA box snoRNAs were detected in TMG-capped group.
Most ncRNAs with an Sm binding site element are TMG-
capped
The snRNAs are critical components of the splicesome,
whose role is to remove introns from exons of immature
mRNAs. In eukaryotes, Sm binding site elements (RAU4–
6G) have been found in most snRNAs, such as U1, U2, U4
and U5 [29,30] and in yeast, maturation of the U3
snoRNA is dependent on some of the Lsm-proteins [31].
In nematodes, spliced leader (SL) RNAs, which participate
in the processing of operonic genes, also have Sm binding
site elements [32]. Binding of Sm proteins is thought to be
a prerequisite for hypermethylation of the m7G cap to
2,2,7-trimethylguanosine by the Tgs1 methyltransferase
[33]. The TMG cap and the associated Sm proteins provide
the nuclear localization signal for the cytoplasmic core
snRNP [33], suggesting that a TMG cap structure is always
linked to the presence of an Sm binding site element. In
our results, there were 22 ncRNAs that had a potential Sm
binding site element, 19 of which were in the TMG-
capped group. Other ncRNA families possibly related to
splicing, such as the Sm Y RNAs, were also found in TMG-
capped group. The potential Sm binding site elements
found in these worm ncRNAs (Figure 2A) were slightly
different from the consensus sequence established for
other organisms (RAU4–6G) [29,30]. The Sm binding site
sequence differed somewhat among the U1, U2 and U4
snRNAs, whereas U5 snRNA, U3 snoRNA and the SL
RNAs and the Sm Y RNAs had very similar potential Sm
binding site elements (consensus sequence AAU4–5GGA;
Figure 2B).
There were also two TMG-capped C/D box snoRNA (U3
and CeN120) that contained potential Sm binding site
elements. Of the remaining 91 ncRNAs, only two
(CeN117 and CeN80) contain a similar pattern, and
CeN117 was precipitated by K121 anti-TMG antibody
with intensity ratios (precipitation/supernatant) above
the threshold. There were also 16 ncRNAs without Sm
binding site element that were enriched in the TMG-anti-
body precipitated fraction, indicating that hypermethyla-
tion of the m7G cap to 2,2,7-trimethylguanosine may
occur independently of the Sm proteins.
TMG cap status and transcription
Primary transcripts synthesized by RNA polymerase II are
modified by addition of a 7-methylguanosine residue to
their triphosphate 5'-end shortly after emergence from the
polymerase. The 7-methylguanosine "caps" of small
nuclear and small nucleolar RNAs are subsequently
hypermethylated to a 2,2,7-trimethylguanosine cap. We
therefore analyzed the relationship between TMG cap
structure and the predicted mode of biogenesis for
Table 1: Intensity ratios (precipitation/supernatant) of 36 ncRNAs assigned to TMG-capped group by R1131
Function Name R1131 K121 Function Name R1131 K121
snRNA U1 CeN1-4 36.547 3.528 C/D snoRNA CeN120 5.710 1.920
CeN1-5 32.501 4.514 CeN30 4.435 3.609
CeN1-1 21.351 4.226 CeN5 4.161 10.919
snRNA U2 CeN18 19.514 4.931 CeN22 3.788 4.177
snRNA U4 CeN2-2 6.481 5.236 CeN27 3.540 3.192
snRNA U5 CeN3-2 24.326 2.749 CeN122 1.730 1.056
CeN3-5 19.875 2.757 U3 snoRNA CeN26-1 3.222 2.323
CeN3-6 15.115 1.503 Sm Y RNA CeN31 34.423 6.568
snRNA SL2 CeN7 17.540 2.887 CeN112 29.063 2.726
CeN12 14.904 4.494 CeN25-4 18.068 2.340
CeN16-1 10.094 2.043 CeN25-1 15.759 2.693
CeN16-3 9.829 2.525 CeN32 13.197 1.267
CeN20 9.524 1.199 CeN115 6.440 3.758
CeN19 7.870 2.492 Other CeN37 28.436 7.172
CeN16-4 7.762 3.218 CeN21-1 20.062 12.289
CeN6 6.915 3.316 CeN35 14.605 9.307
CeN8-1 5.237 1.574 CeN29 13.645 4.423
SnRNA SL1 CeN116 1.963 1.759 CeN23-1 9.368 3.196BMC Molecular Biology 2007, 8:86 http://www.biomedcentral.com/1471-2199/8/86
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ncRNAs in C. elegans. Based on upstream motifs and other
characteristics, ncRNAs in C. elegans have been divided
into four groups [19], of which the first two were assumed
to be transcribed by RNA polymerase II or III, respectively.
The third group comprised ncRNAs processed from
spliced introns with no evident upstream motif, and the
fourth group was composed of other ncRNAs for which
no predictions could be made. Twenty-eight of the 32
ncRNAs predicted to be transcribed by polymerase II [19],
have a TMG-cap structure, the exceptions being four C/D
box snoRNAs (CeN117, CeN121, CeN28 and CeN33),
two of which were precipitated by K121 antibody. On the
other hand, only one of 52 ncRNAs predicted to be tran-
scribed by RNA polymerase III were assigned to the TMG-
capped group. All the 34 intronic snoRNA without
upstream motifs were also in the non-TMG-capped group.
Eight of 9 intergenic ncRNA loci with no distinct upstream
motif were in TMG-capped group, whereas one (CeN113)
had intensity ratios (precipitation/supernatant) around
1.0 and the last one was assigned to the non-TMG group
(Figure 3).
Expression patterns of ncRNAs in TMG-capped group
We next reanalyzed previous microarray expression data
for the C. elegans ncRNAs [24] with respect to cap struc-
ture. The TMG-capped ncRNAs were on average more
highly expressed than non-TMG-capped ones. There were
7 C/D box snoRNAs with a TMG-cap structure, including
snoRNA U3, and these TMG-capped C/D box snoRNAs
had much higher expression levels than other snoRNAs
(Figure 4A).
The expression patterns of the TMG-capped ncRNAs
mainly fall into two groups, one containing splicing
related ncRNAs (Figure 4B) and the other containing box
C/D snoRNAs and functionally unannotated ncRNAs
(Figures 4C and 4D). Splicing related ncRNAs had rela-
tively lower expression levels than those in the other
groups, but displayed greater fluctuations in expression
levels over the developmental stages and stimulated con-
ditions. The two C/D snoRNAs containing an Sm site ele-
ment had very similar expression patterns, and showed
significantly low expression at the earlier development
stages and significantly high expression in dauer (Figure
4C). The other 4 C/D snoRNAs in TMG-capped group had
relative low expression levels, and most displayed little
variation in expression during development (the excep-
tion being CeN5 which was highly expressed in L1 start)
[24].
Cap structure and predicted mode of biogenesis Figure 3
Cap structure and predicted mode of biogenesis. The 
ncRNAs were divided into four groups: those predicted to 
be transcribed by RNA polymerase II (Pol II) or III (Pol III), 
those located in introns with no evident upstream motifs 
(Intronic), and those with intergenic loci with no distinct 
upstream motifs (Other). The numbers of TMG-capped and 
non-TMG-capped ncRNAs were shown for each group.
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Potential Sm binding site elements of TMG-capped ncRNAs Figure 2
Potential Sm binding site elements of TMG-capped 
ncRNAs. (A) The potential Sm binding site elements of C. 
elegans TMG-capped ncRNAs, and (B) their consensus 
sequence.BMC Molecular Biology 2007, 8:86 http://www.biomedcentral.com/1471-2199/8/86
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Expression profiles of capped and non-capped of ncRNAs Figure 4
Expression profiles of capped and non-capped of ncRNAs. Expression levels for ncRNAs assigned to the TMG-capped 
and non-TMG-capped groups. The expression levels are given as the mean Cy3 or Cy5 fluorescence intensity for eight repli-
cates. (B-D) Expression profiles of (B) the splicing related ncRNAs, (C), two C/D snoRNAs with Sm binding sites in the TMG-
capped group, and (D) five uncharacterized C/D snoRNAs in the TMG-capped group during 7 development stages (Egg, L1 
start (L1s), L1, L2, L3, L4 and MA), heatshock (HS) and dauer (Duaer). (The numbers in parenthesis in (B) indicate numbers of 
corresponding ncRNAs.)BMC Molecular Biology 2007, 8:86 http://www.biomedcentral.com/1471-2199/8/86
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There were also 5 non-annotated ncRNAs in the TMG-
capped group. None of these ncRNAs have an Sm site ele-
ment, however, their expression patterns are very similar
to those of the two C/D snoRNAs in the TMG-capped
group containing Sm binding site elements (Figures 4D).
Discussion
The 2,2,7-trimethylguanosine cap structure is conserved
in eukaryotes, and was first found at 5'-end of some
snRNAs [15]. Antibodies against 2,2,7-trimethylguanos-
ine can react with intact TMG-capped snRNPs in various
organisms [18]. Here, our results showed that antibodies
against 2,2,7-trimethylguanosine works well in C. elegans,
and can be used to screen for TMG-capped RNAs.
Previous studies have shown that the R1131 antibody has
a higher specificity for the TMG cap structure than the
K121 antibody, and that the latter has shown some cross-
reactivity with mono-methylated cap structures [25,26].
In our results, the R1131 antibody showed high affinity
than the K121 antibody. There were more ncRNAs with
intensity ratios (precipitation/supernatant) around 1.0 for
the K121 antibody than those for R1131, indicating a
lower efficiency for K121 in precipitation of TMG-capped
ncRNAs than R1131 antibody. In general, precipitate and
supernatant obtained with R1131 showed higher and
lower intensity ratios, respectively, compared to those
obtained with K121. This also possibly indicated that the
R1131 has a higher affinity for TMG cap structures than
the K121 at equal antibody concentrations.
In our previous work, the library construction procedure
included a step to distinguish between 5'-end capped and
non-capped RNAs. The probability of an ncRNA being 5'-
end capped or not was determined [19]. The statistical
model only partially detected the 5'-end capped ncRNAs,
and could not distinguish between different kinds of 5'-
end caps. Immunoprecipitation used here identified all
ncRNAs previously found to be TMG-capped in other
eukaryotes. Using immunoprecipitation and ncRNA chip
strategies, of total 127 examined ncRNAs, we reassigned
or refined the cap structure status previously assigned [19]
for 11 ncRNAs.
With the exception of snRNA U6, which have a simple γ-
methylguanosine cap in other studied organisms, all the
spliceosomal snRNAs have a TMG cap structure [1,30]. In
organisms where snRNA transcription has been investi-
gated, U6 snRNA is always transcribed by RNA polymer-
ase III [34,35], while the other snRNAs are transcribed by
RNA polymerase II [36]. It is believed that the TMG cap
hypermethylation of snRNAs is essential for the mature
snRNAs return to nucleus [12]. Our results were consist-
ent with the hypothesis that TMG capped ncRNAs are
transcribed by RNA polymerase II in the sense that almost
all ncRNAs detected to have a TMG cap structure had pre-
viously been predicted to be transcribed by RNA polymer-
ase II [37].
All previously characterized TMG capped snRNAs, SL
RNAs or snoRNAs have a potential Sm binding site ele-
ments suggesting that binding to Sm proteins may be a
prerequisite for hypermethylation of the m7G cap to
2,2,7-trimethylguanosine by the Tgs1 methyltransferase
[33]. Another conserved sequence element, the box C/D
motif, has also been shown to direct snoRNA 5'-end m7G
hypermethylation [38]. Our results further showed that
also ncRNAs lacking both distinct Sm binding sites and
box C/D elements had an TMG-cap structure suggesting
that there may exist other pathways for hypermethylation
of the m7G cap to 2,2,7-trimethylguanosine.
Conclusion
Combining immunoprecipitation and ncRNA microarray
strategies, we found that 36 ncRNAs in C. elegans were spe-
cifically precipitated by anti-2,2,7-trimethylguanosine
antibodies. As anticipated, ncRNAs enriched by anti-TMG
antibody mainly fall into certain functional categories and
certain biogenesis group. Almost all ncRNAs containing
an Sm binding site also had a TMG cap. Our results also
showed that 16 ncRNAs in TMG-capped group did not
have an Sm binding site element. Almost all ncRNAs in
the TMG-capped group had been predicted to be tran-
scribed by RNA polymerase II, whereas most ncRNAs in
the non-TMG-capped group were assumed to be tran-
scribed by RNA polymerase III or spliced from introns. Six
functionally non-annotated ncRNAs were also found in
the TMG-cap group, which suggests that these ncRNAs
might also be transcribed by RNA polymerase II.
Methods
Immunoprecipitation of TMG-capped RNAs
Immunoprecipitations were done as described by Terns et
al. [39] with some modifications. Briefly, total RNAs were
extracted from mixed stage N2 worms, followed by several
steps to remove mRNA, rRNA, and tRNA [19]. The
remaining RNAs and K121 monoclonal anti-TMG anti-
body (Santa Cruz) or R1131 polyclonal anti-TMG anti-
body [17] (Synaptic System) were incubated in Binding
Buffer (1% TritonX-100, 150 mM NaCl, 2 mM EDTA
pH8.0, 20 mM Tris-HCl pH8.0) overnight at 4°C with
continuous shaking. The RNA-antibody complexes were
coupled to Protein G PLUS-Agarose Beads (Santa Cruz)
for 2 hours at 4°C gentle rotation, and the supernatant
and precipitate (beads) were separated by a gentle centrif-
ugation. RNAs in the supernatant were extracted using Tri-
zol (Invitrogen). The precipitated pellets were washed
four times with cold Low Salt Wash Buffer (1% SDS, 1%
TritonX-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-
HCl pH8.0), once with High Salt Wash Buffer (1% SDS,BMC Molecular Biology 2007, 8:86 http://www.biomedcentral.com/1471-2199/8/86
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1% TritonX-100, 2 mM EDTA, 500 mM NaCl, 20 mM Tris-
HCl pH8.0) and twice with TE Buffer (pH 7.8). The final
pellets were re-suspended in the Elution Buffer (1% SDS,
0.1 M NaHCO3), incubated for 5 min at 4°C with contin-
uous inversion. After a gentle centrifugation, the RNAs in
the supernatant were extracted from the Elution Buffer by
using Trizol. The RNAs from both samples were used for
the microarray strategies.
ncRNA microarray procedures
The ncRNA microarray design has been described previ-
ously [24]. After immunoprecipitation, RNA samples
were dephosphorylated with calf intestine alkaline
phophatase (Fermentas), and ligated to the 3' adaptor oli-
gonucleotide by T4 RNA ligase (Fermentas). The ligated
ncRNAs were reverse transcribed using an oligonucleotide
complementary to the 3' adaptor. The cDNAs from the
supernatant and precipitation fractions were labeled with
Cy5 and Cy3 respectively, using the Fermentas Amino
Allyl cDNA labeling kit. The labeled cDNAs were com-
bined and hybridized to the microarrays. The raw data
were normalized and processed using the MIDAS (TIGR
TM4) software as previously described [24].
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